You are here
US: S&P, Dow hurt by energy, banks; biotech boosts Nasdaq
[NEW YORK] The S&P 500 and Dow stock indexes were weighed down by falling energy shares as oil prices fell on Wednesday and added to investor concerns about low inflation, while healthcare and technology stocks helped lift the Nasdaq Composite index.
Energy was the weakest S&P sector with a 1.6 per cent decline after oil prices reversed course during the morning session and US crude touched its lowest point since August despite larger-than-expected declines in inventories.
Continued weakness in oil futures added to investor worries about inflation and as a result hurt cyclicals such as banks and industrials, according to Chris Zaccarelli, Chief Investment Officer at Cornerstone Financial Partners in Huntersville, North Carolina.
"Because people are seeing oil lower as another harbinger of lower inflation, a lot of other cyclicals (besides energy stocks) aren't doing well," said Mr Zaccarelli.
Bank stocks fell 0.8 per cent as investors worried interest rate margins would be hurt by a flattening yield curve, which is also driven by inflation expectations.
Industrial stocks were also among the biggest decliners with a 0.7 per cent drop. Caterpillar's 3.3 per cent fall weighed on the sector while a 1.6 per cent rise in FedEx was its biggest boost.
Investors looking for growth opportunities turned to Nasdaq, which contains many technology and biotechnology companies, according to Mr Zaccarelli.
Healthcare stocks were helped by reports that US President Donald Trump's efforts to rein in drug prices may be friendlier than expected to the industry, according to Brad McMillan, Chief Investment Officer for Commonwealth Financial in Waltham, Mass.
In general equity investors are biding their time ahead of quarterly results, which are expected to be good.
"We're just continuing to bounce around here until second quarter earnings come out," said Mr McMillan.
The Dow Jones Industrial Average fell 57.11 points, or 0.27 per cent, to close at 21,410.03, the S&P 500 lost 1.42 points, or 0.06 per cent, dropping to 2,435.61 and the Nasdaq Composite added 45.92 points, or 0.74 per cent, rising to 6,233.95.
The energy index has fallen 14.9 per cent so far this year compared with an 8.9 per cent rise for the S&P 500. Oil futures have fallen about 21 per cent so far this year.
The four-company telecommunications sector was the second weakest with a 1.2 per cent drop, with AT&T Inc leading the per centage declines.
The Nasdaq biotechnology index was up 4.1 per cent, on track for its biggest one-day gain since the day after Mr Trump's Nov 8 election. Its biggest boosts were Celgene, and Regeneron which both rose more than 5 per cent and Biogen, which rose 4.7 per cent.
Republicans were due to release details of a bill aimed at overhauling US healthcare law on Thursday and a vote could come as soon as next week, several senators told Reuters. Republicans worked behind closed doors for weeks on the bill. If it passes, some investors see it as a positive sign for Mr Trump's pro-business agenda. Declining issues outnumbered advancing ones on the NYSE by a 1.70-to-one ratio; on Nasdaq, a 1.04-to-one ratio favoured decliners.
About 7.16 billion shares changed hands on US exchanges compared with a 6.92 billion average for the last 20 sessions.